Highlights of the financial year 2017
Net sales
+3.5%
Organic, currency-adjusted net sales growth in 2017
Net sales development
2008 – 2017
2008 – 2017
(in CHF million)
EBIT, EBITDA, Net income,
Earnings per share (EPS)
2015 – 2017
Earnings per share (EPS)
2015 – 2017
(in CHF million)
(EPS: in CHF)
* Adjusted for costs in connection with the Sanitec acquisition and integration
Net income development
2008 – 2017
2008 – 2017
(in CHF million)
* Adjusted for costs in connection with the Sanitec acquisition and integration
Free cashflow
(in CHF)
483 million
-13.2% versus prior year
Adjusted operating cashflow margin
(EBITDA margin)
(EBITDA margin)
28.2%
0.1 percentage points lower than prior year
Payout ratio
63.4%
The payout ratio is in the upper range of the target corridor
of 50 to 70%
of 50 to 70%
Adjusted earnings per share
(in CHF)
(in CHF)
16.43
+3.7% versus prior year
R&D expenditures
(in CHF)
78 million
+6 million versus prior year
Investments in property, plant and equipment and intangible assets
(in CHF)
(in CHF)
159 million
+14.3% versus prior year
Currency effects in net sales
(in CHF)
34 million
Currency effects in EBIT
(in CHF)
(in CHF)